Literature DB >> 18475763

Effect of Complexes of Zinc, Cobalt and Copper With D-Aminosugars on the Replication of Herpes Simplex Virus Type 1 (HSV-1).

S Shishkov1, T Varadinova, M Panteva, P Bontchev.   

Abstract

Our previous results show that Zn(pic)(2) and Zn(asp)(2) inhibit key steps of the replication of HSV-1. Anti-HSV effect of complexes of Co(II) with aminoacids Lys and Ser was also found. In the present study we describe the effect of complexes of Zn(II), Co(II) and Cu(II) with D-aminosugars on the replication of HSV-1 and on the infectivity of free virions. The experiments were done using primary rabbit kidney cells (r.k.), diploid human embryonal fibroblasts (F) and Vero cells. No differences in the toxicity of metal complexes on diploid cells- r.k. and F, were found. Neither metal complexes, nor ligands-galactosoxime and glucosoxime, influenced the viral replication. During 1-4h prolonged contact only Cu(Gl.NOH)(2) inactivated HSV-1 virions up to 90%. The results show that D-aminosugars are not suitable ligands for Zn(II), Cu(II) and Co(II) in respect of the inhibition of viral replication. However, only Cu(Gl.NOH)(2) was able to inhibit the infectivity of free virions.

Entities:  

Year:  1997        PMID: 18475763      PMCID: PMC2365038          DOI: 10.1155/MBD.1997.35

Source DB:  PubMed          Journal:  Met Based Drugs        ISSN: 0793-0291


  5 in total

1.  Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

Authors:  Ji Young Yoo; Jason Pradarelli; Amy Haseley; Jeffrey Wojton; Azeem Kaka; Anna Bratasz; Christopher A Alvarez-Breckenridge; Jun-Ge Yu; Kimerly Powell; Andrew P Mazar; Theodoros N Teknos; E Antonio Chiocca; Joseph C Glorioso; Matthew Old; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

Review 2.  Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells.

Authors:  Dhaval S Sanchala; Lokesh K Bhatt; Kedar S Prabhavalkar
Journal:  Front Pharmacol       Date:  2017-05-16       Impact factor: 5.810

3.  Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.

Authors:  Mike Armour; Alex Semprini; Carolyn Ee; Lois MacCullagh; Nick Shortt
Journal:  BMJ Open       Date:  2020-01-12       Impact factor: 2.692

Review 4.  Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy.

Authors:  Jianfang Ning; Hiroaki Wakimoto
Journal:  Front Microbiol       Date:  2014-06-20       Impact factor: 5.640

5.  ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma.

Authors:  Ji Young Yoo; Jun-Ge Yu; Azeem Kaka; Quintin Pan; Pawan Kumar; Bhavna Kumar; Jianying Zhang; Andrew Mazar; Theodoros N Teknos; Balveen Kaur; Matthew O Old
Journal:  Mol Ther Oncolytics       Date:  2015-05-20       Impact factor: 7.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.